Clinical utility of radiolabeled monoclonal antibodies in prostate cancer.
about
Construction and in vitro/in vivo targeting of PSMA-targeted nanoscale microbubbles in prostate cancer.Selection and characterization of Anticalins targeting human prostate-specific membrane antigen (PSMA).The evolving biology and treatment of prostate cancer.Prostate specific membrane antigen- a target for imaging and therapy with radionuclides.Variant HNF1 modulates epithelial plasticity of normal and transformed ovary cells.Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancerMolecular and functional imaging for detection of lymph node metastases in prostate cancer.Synthesis of the first radiolabeled 188Re N-heterocyclic carbene complex and initial studies on its potential use in radiopharmaceutical applications.
P2860
Q34637387-3FEB7AB2-48B4-479E-8820-4914A06B7BCCQ35902274-D5C796E8-1337-402F-94F2-095A6C9CB3CBQ35951473-2A790F46-86B6-4BAB-BBDA-944D78064B24Q36135685-60CB14EA-F3E1-4817-937B-083C6D4DF689Q36982136-67EDB956-19F5-4AC4-B7C1-147DED2AF46BQ37972920-AE1248E3-BCB0-4CEF-A2D8-3C45E28A3E91Q38119113-6E34D20D-8377-4F0D-9AD9-BE5FD525A037Q42110738-5517326B-2DD5-4211-B527-043CE3E0B911
P2860
Clinical utility of radiolabeled monoclonal antibodies in prostate cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Clinical utility of radiolabeled monoclonal antibodies in prostate cancer.
@ast
Clinical utility of radiolabeled monoclonal antibodies in prostate cancer.
@en
type
label
Clinical utility of radiolabeled monoclonal antibodies in prostate cancer.
@ast
Clinical utility of radiolabeled monoclonal antibodies in prostate cancer.
@en
prefLabel
Clinical utility of radiolabeled monoclonal antibodies in prostate cancer.
@ast
Clinical utility of radiolabeled monoclonal antibodies in prostate cancer.
@en
P2093
P356
P1476
Clinical utility of radiolabeled monoclonal antibodies in prostate cancer.
@en
P2093
David M Nanus
Kevin A David
Lale Kostakoglu
Matthew I Milowsky
Neil H Bander
Shankar Vallabhajosula
Stanley J Goldsmith
P304
P356
10.3816/CGC.2006.N.003
P407
P577
2006-03-01T00:00:00Z